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Bone mineral density (BMD), a diagnostic parameter for osteoporosis and a clinical predictor of fracture, is a polygenic trait with high
heritability. To identify genetic variants that inﬂuence BMD in different ethnic groups, we performed a genome-wide association study
(GWAS) on 800 unrelated Southern Chinese womenwith extreme BMD and carried out follow-up replication studies in six independent
study populations of European descent and Asian populations including 18,098 subjects. In themeta-analysis, rs2273061 of the Jagged1
(JAG1) gene was associated with high BMD (p ¼ 5.27 3 108 for lumbar spine [LS] and p ¼ 4.15 3 105 for femoral neck [FN],
n ¼ 18,898). This SNP was further found to be associated with the low risk of osteoporotic fracture (p ¼ 0.009, OR ¼ 0.7, 95%
CI 0.57–0.93, n ¼ 1881). Region-wide and haplotype analysis showed that the strongest association evidence was from the linkage
disequilibrium block 5, which included rs2273061 of the JAG1 gene (p ¼ 8.52 3 109 for LS and 3.47 3 105 at FN). To assess the func-
tion of identiﬁed variants, an electrophoretic mobility shift assay demonstrated the binding of c-Myc to the ‘‘G’’ but not ‘‘A’’ allele of
rs2273061. A mRNA expression study in both human bone-derived cells and peripheral blood mononuclear cells conﬁrmed association
of the high BMD-related allele G of rs2273061 with higher JAG1 expression. Our results identify the JAG1 gene as a candidate for BMD
regulation in different ethnic groups, and it is a potential key factor for fracture pathogenesis.Osteoporosis is a major public health problem, a disease
characterized by low bone mass, poor bone quality, and
an increased predisposition to fracture. BMD, an important
clinical predictor of fracture, is a complex trait of strong
genetic determination and is associated with a heritability
estimate of 0.6 to 0.8.1–4 Some large cohort studies and
meta-analyses have started to clearly delineate the associa-
tion of certain polymorphisms.5–8 Several genome-wide
association studies (GWAS) have recently conﬁrmed some
associated loci, although they demonstrate only a small
effect size on BMD variation in the general population.9–13
It has also been suggested that genes predisposing to
the risk of osteoporosis vary between different ethnic
groups.14,15 Because BMD is a polygenic trait, it is probable
that many additional associated variants or ethnic-speciﬁc
loci remain to be identiﬁed. The identiﬁcation of addi-
tional genes that determine BMD variation would there-
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The Americaand pathogenetic mechanisms of osteoporosis and offer
strategies for therapeutic development.
In this GWAS, a multistep genome-wide association
strategy (Figure S1 available online) was adopted to iden-
tify additional and/or ethnic-speciﬁc genes and their
variants underlying BMD variation. The association of
genome-wide data was ﬁrst studied in 800 unrelated
Hong Kong Southern Chinese (HKSC) females with
extreme BMD (discovery sample). The most promising
single-nucleotide polymorphisms (SNPs) were then tested
for replication in another 720 HKSC subjects with extreme
BMD (ﬁrst-step replication). An association between repli-
cated SNPs and BMD variation was conﬁrmed in ﬁve other
independent cohorts including 17,378 subjects of Euro-
pean descent or Asian descent (second-step replication).
Finally, a region-wide association study was conducted to
detect the causal variant of identiﬁed gene in the pooled
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Table 1. Description of Studied Populations
Discovery Cohort Replication Cohorts
First Step Second Step
Hong Kong Southern
Chinese Discovery Cohort
Hong Kong Southern
Chinese First-Step
Replication Cohort
Hong Kong Osteoporosis
Study Prospective Cohort
Northern
Chinese
Population
Group High BMD Low BMD High BMD Low BMD BMD Nonfracture Fracture BMD
Number 376 424 264 (168) 456 (124) 1881 1637 244 1584
Age (years) 46.6 5 14.8 51.1 5 15.9 48.3 5 16.3 49.0 5 16.0 62.3 5 8.9 60.7 5 8.2 67.4 5 9.9 56.2 5 11.3
Height (m) 1.58 5 0.06 1.53 5 0.07 1.65 5 0.09 1.57 5 0.08 1.52 5 0.06 1.53 5 0.06 1.50 5 0.06 1.60 5 0.06
Weight (kg) 61.1 5 9.9 49.1 5 6.7 67.1 5 11.4 52.1 5 9.5 55.4 5 9.5 55.7 5 9.5 54.1 5 9.3 59.5 5 9.4
BMD Z-Score
Lumbar Spine 1.05 5 0.78 1.59 5 0.53 1.36 5 0.89 1.34 5 0.72 0.43 5 1.18 0.39 5 1.18 0.72 5 1.17 0.05 5 1.24
Femoral Neck 1.15 5 0.79 1.36 5 0.60 1.01 5 0.84 1.16 5 0.69 0.35 5 0.97 0.29 5 0.97 0.78 5 0.93 0.71 5 0.92
Data are expressed as mean5 standard deviation. The subject number is total number (the number of male subjects, if applicable, is given in parentheses) in each
cohort. A total of 1520 subjects with extreme BMD phenotype were selected from a growing database of Hong Kong Southern Chinese (more than 7000 volun-
teers). The low BMD subjects are defined as an individual having BMD Z-score%1.28 at either lumbar spine (LS) or femoral neck (FN), which is equivalent to the
lowest 10% of the total cohort, while high BMD subjects are individuals with BMD Z-scoreR þ1.0 at either of the two skeletal sites. First, a subset of 800 women
was selected from the Hong Kong Southern Chinese (n ¼ 1520) as the discovery cohort, and then the remainder of individuals (n ¼ 720, 59.4% women) of the
extreme population were used for the first-step replication.replication cohort (n ¼ 1520), and the potential biological
function of the gene variant was further validated.
The characteristics of population are shown in Table 1.
In the discovery stage, 800 unrelated women with extreme
high or low BMD were selected from a HKSC cohort with
extreme BMD (n ¼ 1520). These subjects were selected
from a database (>7000 Southern Han Chinese volunteers)
of the Osteoporosis Centre of the University of Hong
Kong. The low-BMD subjects are deﬁned as an individual
having BMD Z-score %1.28 at either lumbar spine (LS)
or femoral neck (FN) (the lowest 10% of the total cohort),
while high-BMD subjects are individuals with BMD Z-score
Rþ1.0 at either site. Subjects who reported that they had
diseases or environmental factors that may affect BMD
and bone metabolism were excluded. The recruitment
procedure and exclusion criteria have been detailed else-
where.16 Subjects were excluded for having a history of
chronic medical illness, premature menopause below age
40 years, malabsorption, major gastrointestinal operation,
metabolic bone diseases, endocrine disorders including
hyper- and hypothyroidism, or medications that may
affect bone and calcium metabolism, as well as for taking
hormonal replacement therapy, antiosteoporosis medica-
tions, and active vitamin D3 metabolites. BMD (g/cm2)
at LS and FN was measured by dual-energy X-ray absorpti-
ometry (DXA; Hologic QDR 4500 plus, Hologic Waltham,
MA, USA) with standard protocol. The age-corrected and
standardized BMD (mean 0, SD 1), termed BMD Z-scores,
was generated for each gender. The in vivo precision of
the machine was 1.2% and 1.5% for LS and FN BMD,
respectively.17
The discovery sample was genotyped via the Inﬁnium
assay (Illumina, San Diego, CA) with Human610-quad230 The American Journal of Human Genetics 86, 229–239, Februarychip, including 564,214 SNPs. PLINK (version 1.04) was
used for the data management and quality control statis-
tics.18 785 individuals and 488,853 SNPs were retained
for analysis after the exclusion based on strict quality-
control criteria. Subjects were excluded according to the
following criteria: (1) genotyping call rate less than 95%
(n ¼ 5); (2) autosomal heterozygosity less than 27% or
more than 31% (the same ﬁve subjects with low genotyp-
ing call rate); (3) being related or identical to other individ-
uals in the sample (n ¼ 7); and (4) discordance of observed
gender and estimated sex (n¼ 3). SNPs were excluded if (1)
genotyping call rate was 95% or less (1158 SNPs); (2)
Hardy-Weinberg equilibrium (HWE) p value was less
than 1.0 3 104 (904 SNPs); (3) minor allele frequency
(MAF) was less than 0.01 (73,589 SNPs). Finally, the
average genotyping call rate of those retained SNPs was
99.91%.
In the genome-wide association (GWA) scan, the associ-
ation tests of SNPs with standardized BMD were imple-
mented via PLINK (version 1.04). For each SNP, the asymp-
totic p value for the relationship between the number of
minor alleles and BMD was derived from a two-sided
t-statistic assuming the minor allele having an additive
effect. Each SNP was tested for its association with BMD
at both LS and FN. We used the genomic control19 and
EIGENSTRAT20 methods for detecting possible bias result-
ing from population substructure and stratiﬁcation.
Quantile-quantile plots were constructed via R-2.5.2 for
Windows. The entire genome association data and the
LD block structure of genomic region were plotted via Hap-
loview v4.1.21
A two-step replication method was used in this study to
validate the top SNPs identiﬁed from the GWA scan. SNPs12, 2010
from the GWA scan that had a false-positive report proba-
bility of less than 0.5 (corresponding to a p value threshold
of 4.75 3 105 or less) as suggested by Wacholder et al.
(2004)22 and the fact that one in 5000 SNPs is hypothe-
sized as a true positive (according to results from previous
GWAS10,23) were used for the ﬁrst-step replication. Further-
more, SNPs with p value of less than 0.05 in the ﬁrst-step
replication and also those reaching genome-wide sig-
niﬁcance in the pooled analysis conducted in the 1520
HKSC subjects with extreme BMD were further validated
in ﬁve independent cohorts, including the Hong Kong
Osteoporosis Study prospective cohort (n ¼ 1881 women),
a Northern Chinese population (n ¼ 1584 women), and
three in silico replication cohorts: the Framingham Osteo-
porosis Study (FOS, n¼ 3569), the deCODEGenetics Study
(dCG, n ¼ 7610, ~85.6% women), and the TwinsUK Study
(TUK, n ¼ 2734 women). In this GWA, the p value
threshold for GWA signiﬁcance was 1.02 3 107 or less
(Bonferroni correction, 0.05 divided by 488,853 SNPs).
The ﬁrst-step replication sample included the remainder
subjects with extreme BMD (428 females and 292 males)
from the same HKSC extreme cohort, who we did not
included in the discovery phase. SNPs were genotyped
with the high-throughput Sequenom genotyping platform
(Sequenom, San Diego, CA). Genotyping was performed
blind to the phenotype status of the samples and was
repeated in 5% of the samples for veriﬁcation and quality
control. The association analyses were the same as those
used for the discovery cohort. Then the joint analysis
were conducted in the pooled subjects with extreme
BMD including the HKSC discovery cohort and ﬁrst-step
replication cohort (n ¼ 1520).
The three in silico replication cohorts have been well
described previously. The FOS is a community-based,
longitudinal, prospective cohort comprising three genera-
tions of individuals in multigenerational pedigrees and
additional unrelated individuals.9 The dCG is a popula-
tion-based sample for genetics study of complex dis-
eases.11,12 The TUK is a population-based sample of twins
from the UK studying the hereditary basis of a variety of
age-related traits and diseases.10 BMD was measured in
the three cohorts at LS and FN via DXA with standard
protocols (Lunar DPX-L for FOS, Hologic QDR4500A for
dCG, and Hologic QDR2000W for TUK). The three cohorts
were genotyped with the Illumina Inﬁnium Human-
Hap300 or HumanHap550 or HumanCNV370 Beadchip
(TUK and dCG) or the Affymetrix 500K mapping array
plus 50K supplemental array (FOS).
For the FOS cohort, sex- and cohort (Original and
Offspring)-speciﬁc standardized residuals (mean 0, SD 1)
of phenotypes were calculated. GWAS was performed
with linear mixed effects regression models, with ﬁxed
SNP genotype effects, and random individual effects that
correlate within pedigree according to kinship relation-
ship.24 To account for the effect of population substruc-
ture, age- and weight-corrected BMD were also adjusted
for the ﬁrst four principal components from theThe AmericaEIGENSTRAT analysis. For the dCG and TUK cohorts,
age- and weight-corrected BMD was computed for each
sex separately to have a mean 0 and standard deviation
1. Single SNP association tests were performed with an
additive genetic effect model that estimated the effect of
one copy increment of the reference allele for all three
cohorts. The p values were also corrected for genomic
control in the dCG cohort.
Hong Kong Osteoporosis Study prospective cohort: This
population is also a part of the HKSC database with both
BMD and fracture data. A total of 1881 unrelated postmen-
opausal women were prospectively followed for incident
fractures.25,26 The duration of follow-up corresponded to
the time from baseline to the occurrence of fracture, death,
or the last follow-up visit data. A low-traumatic fracture
was deﬁned as a fracture sustained after a fall from standing
height or less. All nonosteoporotic site fractures (nose, toe,
head, jaw, skull, and hands) and traumatic fractures were
excluded. Radiographic morphometric vertebral fractures
were deﬁned by a reduction in vertebral height of at least
3 standard deviations in anterior, mid, or posterior ratios
compared with normative means.27 Fractures were veriﬁed
by retrieval of the X-ray report and hospital discharge
summaries from the computerized patient record system
of the Hospital Authority of the Hong Kong Government.
The Northern Chinese population: 1584 female
Northern Chinese aged 20 years or above were recruited
from three osteoporosis centers (two in Shanghai and
one in Beijing) by posters. All the study subjects are resi-
dents of Shanghai or Beijing and are Chinese of Han origin.
Patients with chronic diseases and conditions that might
potentially affect bone mass and bone metabolism were
excluded with the same exclusion criteria as the HKSC
population.16,28,29 The DXA machine (GE-Lunar Corp. or
Hologic Inc.) was used to measure BMD of the LS and FN
via standard protocols. These two Chinese second-step
replication cohorts were genotyped with the TaqMan
system (Applied Biosystems, Foster City, CA). The statis-
tical procedures of associations between SNP and BMD
variation were the same as those used for the HKSC
discovery cohort, with the addition of an ‘‘osteoporosis
center’’ variable also included as a covariate in the associa-
tion analysis of Northern Chinese population to eliminate
the potential effect of subjects being recruited from
different centers. The logistic regression model was used
to examine the association of SNP with fracture risk by
adjusting for covariates such as age and follow-up dura-
tion. Skeletal site-speciﬁc analyses were also conducted
for spine and hip fractures. These statistical analyses were
performed with SPSS v.16 (SPSS, Chicago, IL).
In all studies, all subjects gave informed consent and the
study protocols were reviewed and approved by local insti-
tutional review boards.
Themeta-analysis of SNPwith BMD variation in (1) all of
the Chinese populations used for the second-step replica-
tion (n ¼ 3,465); (2) all of the second-step replication
subjects of European descent (n ¼ 13,913); and (3) all ofn Journal of Human Genetics 86, 229–239, February 12, 2010 231
Figure 1. Quantile-Quantile Plots of Discovery Test Statistics for
the Genome-wide Associations of Single Nucleotide Polymor-
phisms with Bone Mineral Density
y axis is the observed –log10 (p) values. x axis is the expected –log10
(p) values under the null distribution of no association for studied
genome-wide SNPs, which would be expected to follow the solid
black line. (A) BMD at lumbar spine (LS); (B) BMD at femoral
neck (FN). The green and gray dots are p values without and
with correction of the factor for chi-square statistics of the
genomic control method (l ¼ 1.007 for LS BMD and l ¼ 1.003
for FN BMD), respectively.the studied subjects from seven independent populations
(n ¼ 18,898) were performed via the inverse variance
meta-analysis approach.
Furthermore, to study the association of the identiﬁed
gene with BMD in more detail and to detect the functional
variant, a region-wide and tagSNP-based method followed
by imputation and sequencing was conducted.
Selected SNPs were genotyped with the high-throughput
Sequenom genotyping platform (Sequenom, San Diego,
CA) in all of the HKSC subjects with extreme BMD
(n ¼ 1520). SNPs with genotyping call rate < 90% and
HWE p < 0.001 were excluded. Both single marker- and
LD block-based haplotype association analyses with BMD
were performed with the PLINK (version 1.04). The single
SNP analysis was the same as that used for the HKSC
discovery cohort. The conditional haplotype testingmodel
was also used to assess the correlation structure and iden-
tify the most promising candidate causal variant(s).30
The imputation of genotypes for all untyped SNPs from
HapMap in the studied genomic region was conducted
with the IMPUTE program.31 We used the release 27
HapMap Chinese (CHB [Chinese Han Beijing] and CHD
[Chinese in Denver]) data as the reference panel. The
IGG program32 was used for the integration of HapMap
data and the exportation of IMPUTE format.
Sequencing was conducted in the coding region of iden-
tiﬁed gene and its ~500 bp ﬂanking genomic sequence in
25 high-BMD subjects who carried the protective allele of
the identiﬁed SNP and 25 low-BMD subjects who carried
the risk allele.
In addition, to test the best-ﬁtted genetic model for the
identiﬁed SNP, the likelihood ratio test of the additive or
dominant or recessive regression model (1 df) against the
full 2 df model was performed. The interaction with sex,
age (<50 and >50 years), and menopause was tested with
regression models.
Finally, the potential biological function of the identi-
ﬁed gene variant was studied. The FASTSNP program33
was used for predicting the function of SNPs of interest.
An electrophoretic mobility shift assay (EMSA) was con-
ducted to evaluate the predicted function. The gene
expression in primary human bone-derived cell cultures
(HBDCs) and human peripheral blood mononuclear cells
(PBMCs) were compared among three genotype groups
of identiﬁed SNP.
The results of GWA scan were as follows. 488,853 SNPs
were studied for their associations with BMD at LS and
FN in 800 unrelated HKSC women with extreme BMD.
Quantile-quantile plots (Figure 1) revealed the presence
of a number of SNPs associated with BMD at LS and FN.
A substantial fraction of the most strongly associated
SNPs could have true associations with BMD. There were
many more signiﬁcant associations than expected by
chance. For example, we observed 110 signals with p value
less than 1 3 104, where we would expect less than
50 signals under the null distribution. Population stratiﬁ-
cation was unlikely to be a key confounding factor inﬂu-232 The American Journal of Human Genetics 86, 229–239, Februaryencing BMD association in this GWA scan analysis. First,
the HKSC discovery subjects were selected from a relatively
homogenous and large population belonging to the same
geographical area. Second, the peak association signals per-
sisted after the adjustment for residual population struc-
ture with EIGENSTRAT (Figure S2). Third, the respective
genomic inﬂation factor (l) was 1.007 and 1.003 for
BMD at the LS and FN, indicating no signiﬁcant popula-
tion stratiﬁcation.
In the GWA scan, a total of 62 SNPs with 42 for LS and 27
for FN (Figure S3) exceeded the false-positive report proba-
bility and were used for the ﬁrst-step replication.
Altogether these SNPs represented 40 independent signals
(r2 < 0.2). Among these 62 SNPs, p values of 6 SNPs were
less than 0.05 (with the consistent direction of effect as
the GWA data) in the ﬁrst-step replication (Table S1). Of
these 62 SNPs, the association of rs2273061 in the Jagged1
(JAG1) gene (minor allele G) with high BMD reached the
GWA signiﬁcance with p value (b) being 1.06 3 108
(0.34) and 1.833 106 (0.25) for BMD at LS and FN, respec-
tively, in the joint analysis of HKSC discovery and ﬁrst-step
replication subjects with extreme BMD (n ¼ 1520). The
SNP rs2273061 was then used for the second-step replica-
tion. Within the JAG1 gene region, several SNPs showed
strong associations with BMD at LS and/or FN in the
GWA scan (Figure S4). Two (rs2273061 and rs6133987) of
them had p value less than 4.75 3 105 for BMD in the12, 2010
Table 2. Summary of Association Results of Jagged 1 Gene rs2273061 in the Discovery Cohort and First- and Second-Step Replication
Cohorts
BMD (Effect Estimated in SD) Fracturea
Lumbar Spine Femoral Neck All Spine Hip
A1 A2 MAF p b p b p OR p OR p OR
Discovery Stage
Hong Kong Southern Chinese
discovery cohort (n ¼ 800)
Gb A 0.308 4.73E-05 0.320 5.36E-04 0.270 NA NA NA NA NA NA
First-Step Replication
Hong Kong Southern Chinese
ﬁrst-step replication cohort
(n ¼ 720)
Gb A 0.319 9.06E-05 0.350 5.59E-03 0.180 NA NA NA NA NA NA
Second-Step Replicationc
Hong Kong Osteoporosis Study
prospective cohort (n ¼ 1,881)
Gb A 0.307 2.50E-03 0.120 4.50E-03 0.090 9.00E-03 0.730 0.0630 0.780 1.60E-02 0.480
Northern Chinese
population (n ¼ 1,584)
Gb A 0.346 0.1985 0.043 0.1180 0.043 NA NA NA NA NA NA
Framingham Study cohort
(n ¼ 3,569)
A Gb 0.405 7.02E-03 0.063 0.1050 0.032 NA NA NA NA NA NA
deCODE Genetics Study
(n ¼ 7,610)
A Gb 0.397 7.50E-03 0.051 4.30E-02 0.036 NA NA NA NA NA NA
TwinsUK Study cohort
(n ¼ 2,734)
A Gb 0.407 4.50E-02 0.052 0.0742 0.045
Meta-analysis
Total second-replication
Chinese (n ¼ 3,465)
1.24E-02 0.088 1.49E-02 0.067 NA NA NA NA NA NA
Total second-replication
subjects of European
descent (n ¼ 13,913)
2.63E-04 0.055 2.14E-02 0.037 NA NA NA NA NA NA
Total subjects (n ¼ 18,898) 5.27E-08 0.072 4.15E-05 0.054 NA NA NA NA NA NA
Abbreviations: A1, minor allele; A2, major allele; MAF, minor allele frequency; b, regression coefficient;
OR, odds ratio; NA, not available.
a The results were adjusted for age and follow-up duration.
b The reference allele. p values are two-sided.
c p values of BMD listed in the second-step replication cohorts were one-sided p value.discovery cohort. These two SNPs were in a moderate LD
(D0 ¼ 0.8, r2 ¼ 0.2).
Second-step replication studies veriﬁed the signiﬁcant
ﬁnding of rs2273061 of JAG1 gene with BMD in the initial
GWA analysis (Table 2). The in silico replication in three
independent cohorts of European descent consistently
showed the same direction of the association with G of
rs2273061 being associated with high BMD (all p < 0.05).
The association of rs2273061 with BMDwas also replicated
in the Hong Kong Osteoporosis Study prospective cohort
(p ¼ 0.0025, b ¼ 0.12 for LS and p ¼ 0.0045, b ¼ 0.09 for
FN, n ¼ 1881). Although the replication study in the
Northern Chinese population (n ¼ 1584) failed to reach
statistical signiﬁcance (p > 0.05), which is probably due
to the small sample size, the results also suggested that
the allele G was related to high BMD. So far, the loci
or variant reported to be associated with osteoporosis
generally have small effects on BMD variation.9–13 The
regression coefﬁcient estimated for BMD on genotype (b)The Americais biased because of selection for extremes in BMD. To over-
come this, we estimated the regression coefﬁcient of geno-
type on BMD (b0) because selection on the independent
variable does not bias the regression coefﬁcient.34 To elim-
inate the potential effect of ‘‘winner’s curse,’’ we used the
data from the ﬁrst-step replication cohort instead of the
discovery cohort for estimation. The estimated b¼ b03vari-
ance (BMD Z-score)/2p(1  p), where b0 is the regression
coefﬁcient of using phenotype as the covariate and geno-
type as the response, the variance of phenotype is from
the total HKSC population and p is the frequency of refer-
ence allele. In our HKSC population, the allelic variance
of JAG1 gene rs2273061 explained ~1.3% of LS BMD vari-
ance and ~0.5% of FN BMD variance. The smaller effect
size of rs2273061 in populations of European descent
may be due to a difference in allele frequency between
Asians and Europeans, with the frequency of allele G of
being approximately 0.31 and 0.60 in HKSC and cohorts
of European descent, respectively. We believe that then Journal of Human Genetics 86, 229–239, February 12, 2010 233
Figure 2. Characteristics for the 20 kb
Downstream and Upstream Regions
around the Jagged 1 Gene
(A) The ﬁne scale recombination rate (right
scale) across the studied region (HapMap
rel22_B36); and the log10 (p) values (left
scale) plot for single marker association
results of BMD at lumbar spine (LS, dia-
mond dots) and femoral neck (FN, circle
dots). The colors of dots are coded accord-
ing to the degree of linkage disequilibrium
(LD) with SNP rs2273061 identiﬁed origi-
nally in the genome-wide association
discovery stage (r2 R 0.8 red; 0.5 %
r2 < 0.8 orange; 0.2 % r2 < 0.5 yellow;
r2 < 0.2 white). The solid horizontal line
at the bottom represents the JAG1 gene
region (NCBI_B36) and its vertical bars
represent exons.
(B) LD plot for the studied region based on
the r2 statistic. Blocks connecting SNP
pairs are shaded based on the LD strength
between SNPs by using the disequilibrium
coefﬁcient r2, which are ranged from
0 (white) to 1.0 (black).functional genetic variation of rs2273061 might not be
population speciﬁc but the difference in allele frequency
of the variant allele might contribute to the observed racial
differences in the prevalence of osteoporosis and osteopo-
rotic fractures.
Meta-analysis of rs2273061 in subgroups and all seven
populations also supported the above association of the
JAG1 gene with BMD variation (Table 2). The p values
(b) for the association for all 18,898 subjects were
5.27 3 108 (0.07) for BMD at LS and 4.15 3 105 (0.05)
for BMD at FN, respectively.
Furthermore, as shown in Table 2, the fracture trait
results supported the associations of rs2273061 with oste-
oporotic fractures (p¼ 0.009, OR¼ 0.7, 95%CI 0.57–0.93),
and the association remained signiﬁcant even with site-
speciﬁc analysis of fracture at the spine (p ¼ 0.063,
OR ¼ 0.8, 95% CI 0.60–1.01) or at the hip (p ¼ 0.016,
OR ¼ 0.5, 95% CI 0.26–0.87). The allele G was associated
with lower risk of fracture, which is consistent with its
association with higher BMD. The signiﬁcance was partly
but not completely attenuated if BMDwas added as a cova-
riate in the model of non-site-speciﬁc analysis (p ¼ 0.031,
OR ¼ 0.8, 95% CI 0.58–0.97), suggesting that the effect of
this variant on fracture risk is mediated through both
BMD-dependent and -independent mechanisms. This
ﬁnding is in agreement with the current understanding234 The American Journal of Human Genetics 86, 229–239, February 12, 2010that bone strength is not being
entirely explained by BMD and that
other phenotypes such as bone size
and geometry are important determi-
nants of bone strength and fracture
risk independently of BMD.35
Sequencing of the coding region of
the JAG1 gene and its ~500 bp ﬂank-ing genomic sequence in 25 high-BMD and 25 low-BMD
subjects carrying the variant allele of rs2273061 did not
identify any new variants or mutations, although with
this limited sample size we cannot exclude the existence
of rare variants with large effects.
In the region-wide association analysis, a total of 48 SNPs
were genotyped in the 20 kb ﬂanking regions of JAG1 gene
(Table S2), including 27 tagSNPs selected based on the
HapMap Phase II CHB data with r2 > 0.8; 17 SNPs, poten-
tially functional, or located in 2 kb ﬂanking regions; 2 SNPs
with p value less than 1.0 3 103 in this discovery phase;
and 2 SNPs in high LD with rs2273061 (r2 > 0.8) based on
theHapMapCHBdata.NineSNPs located in exonsorwithin
2 kb ﬂanking regions were monomorphic in the HKSC pop-
ulation. 39 SNPs with genotyping call rate> 90% and HWE
p values > 0.001 were used for statistical analysis.
The single marker association analysis showed that the
strongest association evidence was from the LD block 5
that included seven SNPs located from intron 3 to intron
4 having p values less than 1.0 3 104 (Figure 2). Three
SNPs showed very strong signiﬁcant associations, with
two (rs2273061 and rs7265068) reaching GWA signiﬁ-
cance (p < 1.02 3 107) and the third (rs6514116) almost
reaching the signiﬁcance threshold (p ¼ 1.53 3 107) for
LS BMD (Table S2). These three SNPs are in high LD in indi-
viduals of both Chinese (r2 > 0.9) and European (r2 > 0.7,
Figure 3. Electrophoretic Mobility Shift and Competition Assays
with c-Myc Recombinant Protein and Allelic Variants of SNP
rs2273061 in JAG1
The allele A probe, corresponding to JAG1 intron 3 sequences
centering rs2273061 (underlined in the following sequences)
was prepared by annealing of the Biotin-labeled oligonucleotide
50-GACAACCTGTTACCACTTATTTACCTTCTTTA-30 with the com-
plementary sequence 50-TAAAGAAGGTAAATAAGTGGTAACAGG
TTGTC-30; the allele G probe, prepared by annealing the Biotin-
labeled oligonucleotide 50-GACAACCTGTTACCACTTGTTTACC
TTCTTTA-30 with the complementary sequences 50-TAAAGAAG
GTAAACAAGTGGTAACAGGTTGTC-30. Electrophoretic mobility
shift assay (EMSA) was conducted with a commercial kit (Pano-
mics, Fremont, CA). 1 ng of Biotin-labeled probe was incubated
with 0.36 mg of c-Myc recombinant protein for 30 min at 15C
in a 10 ml reaction volume containing 2 ml 5 3 binding buffer
and 1 mg poly d(I-C). For competition reactions, the unlabeled
probe was used at 660-fold molar excess of the labeled probe. After
incubation, the samples were separated by electrophoresis on a 6%
nondenaturing polyacrylamide gel with 0.5 3 TBE buffer. DNA-
protein complexes were electroblotted to Pall Biodyne B nylon
membrane (Pall Corp., Pensacola, FL) and visualized by exposure
to Chemiluminescent Detection Film (Agfa, Shanghai, China).
Lanes: 1, labeled A probe; 2, labeled A probe þ c-Myc; 3, labeled A
probe þ c-Myc þ unlabeled A probe; 4, labeled G probe; 5, labeled
G probeþ c-Myc; 6, labeled G probeþ c-Mycþ unlabeled G probe.
Bindingwas not observed with oligonucleotide containing A allele
(lane 2) but was present with oligonucleotide containing the
G allele (lane 5). Binding to the G allele resulted in a complex
that was speciﬁcally competed by unlabeled mutant probe con-
taining the G allele (lane 6).CEU) descent. In silico replication of rs6514116 and
rs7265068 conﬁrmed the same direction of association
with BMD in the three replication cohorts of European
descent (p < 0.05). In the haplotype analyses, the most
signiﬁcant association signals were detected in LD block
5 of the JAG1 gene with p value being 8.52 3 109 for LS
and 3.47 3 105 for FN (Table S3). The haplotype data cor-
responded to the single marker analysis, but did not add
further information to outcome. The conditional haplo-
type analysis revealed that the global association was
largely attenuated (even disappeared) when conditioned
on any of the most signiﬁcant three SNPs (p ¼ 0.0168 for
LS and p ¼ 0.2804 for FN), which may suggest that the
signiﬁcant haplotype associations were mostly derived
from the effects of those three SNPs.
Subsequently, the imputation analysis further supported
that the three SNPs rs6514116, rs2273061, and rs7265068
appeared consistently with the strongest association
signals with BMD variation (Figure S5). All together, 82
SNPs in this studied region were included in the associa-
tion analyses. Of these 82 SNPs, 43 were imputed SNPs
that are extracted from the HapMap database with
MAF R 0.01 and 39 were genotyped SNPs in this study.
Additional analyses revealed that: (1) the additive model
(1 df) best ﬁtted the data for all of rs6514116, rs2273061,
and rs7265068 (p > 0.8) and neither the dominant nor
recessive (p < 0.01) model yielded an adequate ﬁt when
tested against the full 2 df model; (2) effects on BMD
were not signiﬁcantly different between females andmales
(p > 0.1); in subjects of age > 50 years compared to those
aged < 50 years (p > 0.1); and for women before or after
menopause (p > 0.1); (3) the associations of these SNPs
with BMD persisted even with the adjustment of height
and weight: the p values of rs6514116, rs2273061, and
rs7265068 were 6.34 3 105, 5.76 3 106, and 2.41 3
106 for LS and 0.0270, 0.0053, and 0.0024 for FN,
respectively.
The bioinformatics analyses suggested that the allele
change (A to G) at rs2273061 located in intron 3 could
generate one binding site for the transcription factor
c-Myc (v-myc myelocytomatosis viral oncogene homolog
[avian] [MIM 190080]; Figure S6). To conﬁrm this, an elec-
trophoretic mobility shift assay (EMSA) was performed
with recombinant c-Myc protein (Abnova Corporation)
and double-stranded oligonucleotide probes (Sigma-
Aldrich Corp., St. Louis, MO). The EMSA results veriﬁed the
speciﬁc binding of c-Myc to the oligonucleotide sequence
containing G but not A nucleotide of rs2273061 (Figure 3).
c-Myc is ahelix-loop-helix (HLH) transcription factor that is
also expressed in osteoblasts and chondrocytes.36,37 Studies
found that the c-Myc transcript levels remained almost
constant during the differentiation ofmurine preosteoblast
MC3T3-E1 cells and that the forced expressionof c-Myc can
signiﬁcantly increase the alkaline phosphatase expression
and osteocalcin gene expression.38 Furthermore, we docu-
mented a signiﬁcant relation between rs2273061 genotype
andmRNA expression of JAG1 in humanbone-derived cellsThe America(Figure 4A) and peripheral blood mononuclear cells
(Figure 4B) with AA subjects having lower JAG1 mRNA
expression than GG subjects. Quantitative real-time PCR
studies from peripheral blood mononuclear cells revealed
that the subjects with GG genotype had approximately
30-fold higher JAG1 mRNA expression levels than did
subjects with AA genotype (p¼ 0.037, Figure 4C). However,
the function of rs2273061 on JAG1 gene expression in oste-
oblasts will need to be further conﬁrmed via chromatin
immunoprecipitation (ChIP) assay and luciferase reporter
assay. Further investigation including allelic-speciﬁc tran-
scription study in heterozygotes for rs2273061 could help
to conﬁrm that the association observed is mediated by
a difference in JAG1 expression.n Journal of Human Genetics 86, 229–239, February 12, 2010 235
Figure 4. JAG1 Gene Expression in
Subjects with Different rs2273061 Geno-
types
(A and B) JAG1 mRNA expression normal-
ized to GAPDH by reverse transcription
PCR (RT-PCR) in human bone-derived cells
(HBDCs, A) and peripheral blood mono-
nuclear cells (PBMCs, B) from individual
subjects with GG, GA, and AA genotype
of rs2273061.
(C) The relative quantity of JAG1 mRNA
expression normalized to ribosomal RNA
by quantitative real-time PCR (q-PCR) in
PBMCs from individuals with different
rs2273061 genotypes (n ¼ 20 per geno-
type, results are mean5 SD).
HBDCs and PBMCs from healthy subjects
were isolated as described previously.46,47
Total RNA was extracted from HBDCs
and PBMCs with Trizol reagent according
to the manufacturer’s instruction (Invitro-
gen, CA). 0.5 mg RNA was used for cDNA
synthesis by M-MLV Reverse Transcriptase
according to the manufacturer’s protocol
(Invitrogen, CA). (A) and (B) showed JAG1
gene expression with RT-PCR with primers
(50-TCGAGTTGGAGATCCTGTCC-30) and
(50-GGGTGTGGGATGCACTTATC-30) spanning exon 2 to 4 with annealing temperature at 59C. Results were normalized to GAPDH
gene expression with primers (50-GCCTCCTGCACCACCACC-30) and (50-CCGTTCAGCTCAGGGATGA-30). (C) showed q-PCR results
with Taqman one-step PCR master mix kit with gene-speciﬁc target primers and 3-FAM probes of JAG1 gene (ABI gene expression assay
ID number Hs00164982_m1). Each sample was simultaneously quantiﬁed with eukaryotic 18S primers and target probes (ABI gene
expression assay 4319413E). Ampliﬁcation was performed in an ABI Prism 7000 sequence detector, with standard settings of 40 cycles
with an annealing temperature of 60C. All samples were assayed in duplicates. Results were expressed as fold-change of JAG1 gene
expression of GG and GA genotypes relative to AA genotype by comparative Ct method (2DDCT). q-PCR in PBMCs revealed the GG
genotype group had approximately 30-fold higher JAG1 mRNA expression levels than the AA genotype group (p ¼ 0.037, t test).Recent studies have reported the involvement of the
JAG1 gene in bone formation. The JAG1 gene encodes
a cell surface protein—Jagged 1—belonging to the Delta/
Serrate domain (DSL) family, which is the ligand binding
to Notch receptors. Expression of JAG1 has been reported
in osteoblastic cells in vivo and in vitro and during bone
regeneration. Activation of JAG1 gene is associated with
increased bone mineral deposition.38 Jagged1 protein was
detected in trabecular osteoblasts and endosteal osteo-
blasts, but not in periosteal cortical osteoblasts, and its
expression was increased with intermittent parathyroid
hormone treatment.39
Mutations in the JAG1 gene are associated with the Ala-
gille syndrome (AGS [MIM 118450]), a multisystem devel-
opmental disorder with autosomal dominant inheri-
tance.40–42 Vertebral deformities and shortened vertebral
body are reported in many patients with AGS.43 The asso-
ciation of AGS with vertebral deformities and the differen-
tial expression pattern of the JAG1 in trabecular rather
than cortical osteoblasts39 is in line with the observed
results in this study that the variants in JAG1 gene are
more signiﬁcantly associated with BMD variation at LS
than FN, because spine comprises mostly trabecular bone
whereas hip has 50% cortical and 50% trabecular bone.
Apart from JAG1, it is likely that many more sequence
variations on BMD determination are yet to be identiﬁed.
Besides the two SNPs in the JAG1 gene, four SNPs in two236 The American Journal of Human Genetics 86, 229–239, Februarygenomic regions were also replicated in the ﬁrst-step repli-
cation population but did not reach a GWA signiﬁcance of
p < 1.02 3 107 in pooled analyses. These variants may
account for some of the remaining heritability of BMD
and deserve further investigation in a large population.
Indeed, evidence for replication in some loci identiﬁed
from the recently published large meta-analysis of GWAS
of ﬁve populations of European descent44 was seen in
our HKSC population, although they were not prominent
in this GWA scan data. Of the reported 25 GWA signiﬁcant
SNPs in 20 loci, 14 SNPs in 10 loci, i.e., 50% of reported
association signals observed in persons of European
descent, were replicated in our HKSC discovery sample
with a consistent direction of effect (p < 0.05; Table S4).
With the most signiﬁcant and independent SNP
(r2 < 0.2) from these 10 replicated loci, the 10 SNPs
combined explained ~3.5% and ~3.9% of the variance of
BMD at LS and FN in the HKSC population, respectively.
Together with the effect of JAG1 gene, ~4.8% and ~4.4%
of the BMD variance at LS and FN was explained, respec-
tively. Failure to replicate the other variants may have
been due to differences in ethnicity or sampling methods
or sample size. The selected extreme sampling strategy was
adopted because it has a substantially greater statistical
power over a random sample for detection of allelic associa-
tion,butourdiscovery samplemayhave lesspower todetect
variants with modest effect. Overall, the pooled discovery12, 2010
and ﬁrst replication sample of 1520 subjects with extreme
BMD have a 84% power to detect a variant with 1% effect
on the BMD variation at a p< 1.03 107 signiﬁcance level
(assuming MAF¼ 0.3, LD¼ 1, Genetic power calculator).45
In conclusion, this study identiﬁed the JAG1 gene
(20p11.23-p12.1) as a candidate for BMD regulation and
a potential key factor for fracture pathogenesis. We also
replicated some genomic loci/variants that have been
reported to be associated with BMD variation. This study
provides new insight into the complex genetic architecture
of osteoporosis. The identiﬁed variants warrant further bio-
logical and clinical investigation.Supplemental Data
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